Long-term Effect of Pulmonary Rehabilitation under Nintedanib treatment in Idiopathic Pulmonary Fibrosis
Phase of Trial: Phase IV
Latest Information Update: 11 Sep 2017
At a glance
- Drugs Nintedanib (Primary)
- Indications Idiopathic pulmonary fibrosis
- Focus Therapeutic Use
- Acronyms FITNESS
- 01 Sep 2017 Planned number of patients changed from 80 to 84.
- 01 Sep 2017 Status changed from not yet recruiting to recruiting.
- 24 May 2017 Trial design presented at the 113th International Conference of the American Thoracic Society